These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8730248

  • 1. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
    Lazzaroni M, Sangaletti O, Bargiggia S, Bensi G, Canali A, Bianchi Porro G.
    Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
    [Abstract] [Full Text] [Related]

  • 2. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
    Hemery P, Congard P, Galmiche JP, Bonfils S.
    Drugs; 1988 Apr; 35 Suppl 3():76-81. PubMed ID: 2905253
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized trial of roxatidine 150 mg in the early evening versus bedtime administration in the short-term treatment of duodenal ulcer.
    Lazzaroni M, Canali A, Bianchi Porro G.
    Aliment Pharmacol Ther; 1995 Aug; 9(4):425-31. PubMed ID: 8527619
    [Abstract] [Full Text] [Related]

  • 4. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
    Merki HS, Witzel L, Kaufmann D, Kempf M, Müssig V, Neumann J, Scheurle E, Röhmel J, Walt RP.
    Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
    [Abstract] [Full Text] [Related]

  • 5. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
    Savarino V, Mela GS, Zentilin P, Cutela P, Vigneri S, Termini R, Di Mario F, Ferrana M, Malesci A, Belicchi M, Celle G.
    Fundam Clin Pharmacol; 1996 Feb; 10(3):304-8. PubMed ID: 8836705
    [Abstract] [Full Text] [Related]

  • 6. [Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer].
    Bosseckert H, Ernst R, Kriech W, Schunter C.
    Med Klin (Munich); 1993 Nov 15; 88(11):637-41. PubMed ID: 7905185
    [Abstract] [Full Text] [Related]

  • 7. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
    Merki HS, Witzel L, Kaufmann D, Kempf M, Muessig V, Neumann J, Scheurle E, Roehmel J, Walt RP.
    Scand J Gastroenterol Suppl; 1988 Nov 15; 146():142-52. PubMed ID: 2906458
    [Abstract] [Full Text] [Related]

  • 8. Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
    Smith JT, Pounder RE.
    Gut; 1990 Mar 15; 31(3):291-3. PubMed ID: 1969833
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
    Gilinsky NH, Bright-Asare P, Cobert BL, Fitch DD, Lanza FL, Kerr RM, Savitsky JP.
    Am J Gastroenterol; 1992 Jul 15; 87(7):847-53. PubMed ID: 1352083
    [Abstract] [Full Text] [Related]

  • 10. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS, Witzel L, Kaufmann D, Kempf M, Neumann J, Scheurle E, Röhmel J, Walt RP.
    Drugs; 1988 Jul 15; 35 Suppl 3():69-75. PubMed ID: 2905252
    [Abstract] [Full Text] [Related]

  • 11. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U, Chinapak O, Vongphanich V, Kositchaiwat C, Lekhayananda S, Khow-ean U, Suttinont C, Saowaros V, Kludchareon N, Leethochawalit M.
    J Med Assoc Thai; 1995 Dec 15; 78(12):641-7. PubMed ID: 8868007
    [Abstract] [Full Text] [Related]

  • 12. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
    Zuberi SJ, Khan AQ, Irshad-ul-Haque I, Hussain A, Hasnain SS, Shah S, Sadick A, Yusuf MZ, Reuter M.
    Clin Ther; 1996 Dec 15; 18(6):1207-12. PubMed ID: 9001837
    [Abstract] [Full Text] [Related]

  • 13. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
    Savarino V, Mela GS, Zentilin P, Bonifacino G, Moretti M, Valle F, Celle G.
    Dig Dis Sci; 1989 Jul 15; 34(7):1043-6. PubMed ID: 2568246
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U, Wagner S, Sieberth HG, Klotz U.
    Br J Clin Pharmacol; 1995 Feb 15; 39(2):161-7. PubMed ID: 7742154
    [Abstract] [Full Text] [Related]

  • 15. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
    Hentschel E, Schütze K.
    Drugs; 1988 Feb 15; 35 Suppl 3():96-101. PubMed ID: 2905256
    [Abstract] [Full Text] [Related]

  • 16. Roxatidine in duodenal ulcer.
    Habibullah CM, Habeeb MA, Singh SP.
    J Postgrad Med; 1995 Feb 15; 41(3):64-5. PubMed ID: 10707717
    [Abstract] [Full Text] [Related]

  • 17. Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482.
    Wilder-Smith CH, Merki HS.
    Scand J Gastroenterol; 1991 May 15; 26(5):501-7. PubMed ID: 1678550
    [Abstract] [Full Text] [Related]

  • 18. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G.
    J Clin Pharmacol; 1987 Oct 15; 27(10):790-3. PubMed ID: 2892864
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG, de Looze SM, Bender W, Labs R.
    Scand J Gastroenterol Suppl; 1988 Oct 15; 146():121-34. PubMed ID: 2906456
    [Abstract] [Full Text] [Related]

  • 20. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
    Fock KM, Kang JY, Ng HS, Ng TM, Gwee KA, Lim CC.
    J Gastroenterol Hepatol; 1995 Oct 15; 10(4):379-82. PubMed ID: 8527701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.